表紙
市場調查報告書
商品編碼
1064722

高鉀血症補充品的全球市場:2021年∼2027年

Global Hyperkalemia Supplement Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 126 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球高鉀血症補充品的市場規模,在預測期間內預計以大幅度的年複合成長率擴大。由於慢性腎臟病和心血管相關疾病等慢性疾病增加,在預測期間內預計大幅推動該市場的成長。可是,已通過核准的高鉀血症的治療藥不足和開發平台弱,可能妨礙在預測期間內的市場擴大。

本報告提供全球高鉀血症補充品市場相關調查,市場概要,以及藥物,各疾病類型,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 市場區隔

  • 全球高鉀血症補充品市場,各藥物
    • 環矽酸鈉鋯
    • Beta2促效劑
    • 聚苯乙烯磺酸鹽酸鈉
    • 其他
  • 全球高鉀血症補充品市場,各疾病類型
    • 急性高鉀血症
    • 慢性高鉀血症

第5章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • AstraZeneca PLC
  • Ardelyx, Inc.
  • Vifor Pharma Management Ltd.
  • Sanofi SA
  • Perrigo Company PLC
目錄
Product Code: OMR2024208

Global Hyperkalemia Drugs Market Size, Share & Trends Analysis Report, By Drug (Sodium Zirconium Cyclosilicate, Beta2 Agonist, Sodium Polystyrene Sulfonate, Other), By Type of Disease (Acute Hyperkalemia, Chronic Hyperkalemia)Forecast (2021-2027)

The global hyperkalemia drugs market is anticipated to grow at a considerable CAGR during the forecast period. The increasing prevalence of chronic diseases such as chronic kidney diseases and cardiovascular-related disorders is expected to contribute heavily of the growth of the market during the forecast. However, lack of approved therapies and weak pipeline for hyperkalemia may hamper the market growth during the forecast period.

The global hyperkalemia drugs market is segmented based on drug and type of diseases . On the basis of drug, the market is sub-segmented into sodium zirconium cyclosilicate, beta2 agonist, sodium polystyrene sulfonate, other. On the basis of type of disease, the market is bifurcated into acute hyperkalemia, chronic hyperkalemia.

Geographically, the global Hyperkalemia Drugs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Some of the companies operating in the global hyperkalemia drugs market include AstraZeneca PLC, Ardelyx Inc., Vifor Pharma Management Ltd, Sanofi SA, Perrigo Company PLC, and many others.

Market Segmentation

1. Global Hyperkalemia Drugs Market Research and Analysis by Drug

2. Global Hyperkalemia Drugs Market Research and Analysis by Type of Disease

The Report Covers

  • Comprehensive research methodology of the global hyperkalemia drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global hyperkalemia drugs market.
  • Insights about market determinants that are stimulating the global hyperkalemia drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Hyperkalemia Supplement Market by Drug
    • 4.1.1. Sodium Zirconium Cyclosilicate
    • 4.1.2. Beta2 Agonist
    • 4.1.3. Sodium Polystyrene Sulfonate
    • 4.1.4. Others
  • 4.2. Global Hyperkalemia Supplement Market by Type of Disease
    • 4.2.1. Acute Hyperkalemia
    • 4.2.2. Chronic Hyperkalemia

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AstraZeneca PLC
  • 6.2. Ardelyx, Inc.
  • 6.3. Vifor Pharma Management Ltd.
  • 6.4. Sanofi SA
  • 6.5. Perrigo Company PLC

LIST OF TABLES

  • 1. GLOBAL HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY DRUG, 2020-2027 ($ MILLION)
  • 2. GLOBAL SODIUM ZIRCONIUM CYCLOSILICATE IN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL BETA2 AGONIST IN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SODIUM POLYSTYRENE SULFONATE IN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL OTHER DRUGS IN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY TYPE OF DISEASE, 2020-2027 ($ MILLION)
  • 6. GLOBAL HYPERKALEMIA SUPPLEMENT FOR ACUTE HYPERKALEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL HYPERKALEMIA SUPPLEMENT FOR CHRONIC HYPERKALEMIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. NORTH AMERICAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 9. NORTH AMERICAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY DRUG, 2020-2027 ($ MILLION)
  • 10. NORTH AMERICAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY TYPE OF DISEASE, 2020-2027 ($ MILLION)
  • 11. EUROPEAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. EUROPEAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY DRUG, 2020-2027 ($ MILLION)
  • 13. EUROPEAN HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY TYPE OF DISEASE, 2020-2027 ($ MILLION)
  • 14. ASIA-PACIFIC HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. ASIA-PACIFIC HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY DRUG, 2020-2027 ($ MILLION)
  • 16. ASIA-PACIFIC HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY TYPE OF DISEASE, 2020-2027 ($ MILLION)
  • 17. REST OF THE WORLD HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY DRUG, 2020-2027 ($ MILLION)
  • 18. REST OF THE WORLD HYPERKALEMIA SUPPLEMENT MARKET RESEARCH AND ANALYSIS BY TYPE OF DISEASE, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HYPERKALEMIA SUPPLEMENT MARKET SHARE BY DRUG, 2020 VS 2027 (%)
  • 2. GLOBAL HYPERKALEMIA SUPPLEMENT MARKET SHARE BYTYPE OF DISEASE, 2020 VS 2027 (%)
  • 3. GLOBAL HYPERKALEMIA SUPPLEMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD HYPERKALEMIA SUPPLEMENT MARKET SIZE, 2020-2027 ($ MILLION)